Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients
NCT04107311
·
clinicaltrials.gov ↗
RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Sponsor
University Health Network, Toronto